S&P Global Inc/ US78409V1044 /
31/05/2024 21:59:59 | Diferencia +6.02 | Volumen | Bid- | Ask- | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
427.53USD | +1.43% | 27,259 Volumen de negocios: 11.53 millones |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 133.77 mil millonesUSD | 0.84% | 51.82 |
GlobeNewswire
2:38
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
1:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página